Amgen Inc. buy tamam
Start price
16.06.17
/
50%
€147.78
Target price
11.09.17
€164.89
Performance (%)
12.61%
End price
11.09.17
€165.38
Summary
This prediction ended on 11.09.17 with a price of €165.38. The prediction had a final performance of 12.61%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | 12.634% | 12.634% | 13.322% | 42.961% |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by tamam for this prediction
In the thread Amgen Inc. diskutieren
tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
tamam stimmt am 16.06.2017 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 182.81$ zu.
(Zielkurs erreicht)


